E&Investment, Inc. - 26 Jul 2022 Form 4 Insider Report for NeuroBo Pharmaceuticals, Inc. (MTVA)

Role
10%+ Owner
Signature
/s/ E&I Investment, Inc., By: Na Yeon Kim, CEO
Issuer symbol
MTVA
Transactions as of
26 Jul 2022
Net transactions value
$0
Form type
4
Filing time
28 Jul 2022, 21:23:57 UTC
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NRBO Common Stock Other $0 -1,445,267 -33% $0.000000 2,890,533 26 Jul 2022 Held by The E&Healthcare Investment Fund II F1, F2, F3
holding NRBO Common Stock 140,147 26 Jul 2022 Direct F4
holding NRBO Common Stock 1,121,190 26 Jul 2022 Held by The E&Healthcare Investment Fund No. 6 F3, F5
holding NRBO Common Stock 1,864,799 26 Jul 2022 Held by The E&Healthcare Investment Fund No. 7 F3, F6
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 E&Healthcare Investment Fund II distributed 1,445,267 shares to its partners on a pro rata basis, for no consideration.
F2 These shares are owned directly by The E&Healthcare Investment Fund II, a 10% owner of the Issuer, and indirectly by its sole general partner, E&Investment, Inc.
F3 E&Investment, Inc. disclaims beneficial ownership of the reported securities except to the extent of its pecuniary interest therein.
F4 E&Investment, Inc. received a pro rata distribution from E&Healthcare Investment Fund II.
F5 These shares are owned directly by The E&Healthcare Investment Fund No. 6, and indirectly by its sole general partner, E&Investment, Inc.
F6 These shares are owned directly by The E&Healthcare Investment Fund No.7, and indirectly by its sole general partner, E&Investment, Inc.